Temsirolimus: is improved survival the correct expression of drug activity?

Oncologist. 2010;15(7):790-1; author reply 792. doi: 10.1634/theoncologist.2010-0099.

Abstract

The article comments on the drug approval summary for temsirolimus published recently in The Oncologist in regard to the difference observed between the investigators' and independent reviewers' assessments.

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / mortality*
  • Sirolimus / analogs & derivatives*
  • Sirolimus / therapeutic use
  • Survival Analysis

Substances

  • Antineoplastic Agents
  • temsirolimus
  • Sirolimus